Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19

Coronavirus disease-19 (COVID-19), a devastating respiratory illness caused by SARS-associated coronavirus-2 (SARS-CoV-2), has already affected over 64 million people and caused 1.48 million deaths, just 12 months from the first diagnosis. COVID-19 patients develop serious complications, including s...

Descripción completa

Detalles Bibliográficos
Autores principales: Thimmulappa, Rajesh K., Mudnakudu-Nagaraju, Kiran Kumar, Shivamallu, Chandan, Subramaniam, K.J.Thirumalai, Radhakrishnan, Arun, Bhojraj, Suresh, Kuppusamy, Gowthamarajan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899028/
https://www.ncbi.nlm.nih.gov/pubmed/33655086
http://dx.doi.org/10.1016/j.heliyon.2021.e06350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899028/
https://www.ncbi.nlm.nih.gov/pubmed/33655086
http://dx.doi.org/10.1016/j.heliyon.2021.e06350

Ejemplares similares